prikaz prve stranice dokumenta Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia
  Preuzmi
PDF 297.43 KB
Znanstveni rad - Izvorni znanstveni rad
Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia
Medicinski Glasnik, 11 (2013), 1; 138-144. urn:nbn:hr:184:948533
Orlić, Lidija; Sladoje-Martinović, Branka; Mikolašević, Ivana; Pavletić Peršić, Martina; Bubić, Ivan; Jelić, Ita; Rački, Sanjin

Citirajte ovaj rad

Orlić, L., Sladoje Martinović, B., Mikolašević, I., Pavletić Peršić, M., Bubić, I., Jelić, I. i Rački, S. (2013). Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia. Medicinski Glasnik, 11. (1), 138-144. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:184:948533

Orlić, Lidija, et al. "Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia." Medicinski Glasnik, vol. 11, br. 1, 2013, str. 138-144. https://urn.nsk.hr/urn:nbn:hr:184:948533

Orlić, Lidija, Branka Sladoje Martinović, Ivana Mikolašević, Martina Pavletić Peršić, Ivan Bubić, Ita Jelić i Sanjin Rački. "Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia." Medicinski Glasnik 11, br. 1 (2013): 138-144. https://urn.nsk.hr/urn:nbn:hr:184:948533

Orlić, L., et al. (2013) 'Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia', Medicinski Glasnik, 11(1), str. 138-144. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:948533 (Datum pristupa: 14.01.2025.)

Orlić L, Sladoje Martinović B, Mikolašević I, Pavletić Peršić M, Bubić I, Jelić I, i sur.. Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia. Medicinski Glasnik [Internet]. 2013. [pristupljeno 14.01.2025.];11(1):138-144. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:948533

L. Orlić, et al., "Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia", Medicinski Glasnik, vol. 11, br. 1, str. 138-144, 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:948533. [Citirano: 14.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:948533
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Acute antibody-mediated rejection of the kidney transplant – experience of a single center in Croatia
AutorLidija Orlić
AutorBranka Sladoje-Martinović
AutorIvana Mikolašević
AutorMartina Pavletić Peršić
AutorIvan Bubić
AutorIta Jelić
AutorSanjin Rački
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Aim To describe the experience of the Department of Nephrology and Dialysis, University Hospital Rijeka, Croatia, in the treatment of patients with acute humoral rejection (AHR) of kidney transplant by using high dose of intravenous immunoglobulin (IVIG) alone and as a first line treatment. Methods Eight kidney transplant recipients in whom the AHR appeared at different time after the transplantation were reported. At the time of transplantation cross-match in all patients was negative for both T and B cells. At the time of presentation, all patients had signs of renal allograft dysfunction and the rejection was proven by biopsy of the kidney transplant with positive C4d-staining and histopathological evidence of antibody-mediated injury. Early rejection was considered within 180 days after the transplantation and the late one 180 days after the transplantation. In two cases plasmapheresis (PAF) with albumin as replacement fluid was performed. Plasma exchange was done with a 35 mL/kg/body weight volume exchange with albumin for six times. Results Acute humoral rejection was classified as early in three patients and in five as late one. In two patients PAF had been performed as the first line treatment. After the completion of PAF, recuperation of severe graft dysfunction was incomplete and in addition IVIG (as a single dose of 2.0 g/kg) was administered to these patients. In six patients IVIG as a single dose of 2.0 g/kg was applied as the first line treatment. Conclusion Usage of high dose IVIG in the treatment of the acute humoral rejection is efficient, safe and relatively well tolerated
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMedicinski Glasnik
Brojčani podacivol. 11, br. 1, str. 138-144
p-ISSN1840-0132
URN:NBNurn:nbn:hr:184:948533
Datum objave publikacije2013
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Bez prerada 4.0 međunarodna (CC BY-ND 4.0)
Datum i vrijeme pohrane2020-11-25 14:39:42